These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9710920)

  • 61. Control of bovine virus diarrhoea-mucosal disease in cattle: examples of the combined use of serological screening, viral antigen detection and vaccination.
    Thibault JC; Crevat D; Chappuis G
    Rev Sci Tech; 1993 Jun; 12(2):471-81. PubMed ID: 8400387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The immune response to bovine viral diarrhea virus: a constantly changing picture.
    Chase CC; Elmowalid G; Yousif AA
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):95-114. PubMed ID: 15062477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Diagnosis of bovine virus diarrhoea/mucosal disease (BVD) under consideration of the present epizootic situation (author's transl)].
    Gründer HD; Hofmann W; Gössler R
    Dtsch Tierarztl Wochenschr; 1981 Mar; 88(3):94-7. PubMed ID: 6260455
    [No Abstract]   [Full Text] [Related]  

  • 65. Noncytopathic bovine viral diarrhea virus can persist in testicular tissue after vaccination of peri-pubertal bulls but prevents subsequent infection.
    Givens MD; Riddell KP; Walz PH; Rhoades J; Harland R; Zhang Y; Galik PK; Brodersen BW; Cochran AM; Brock KV; Carson RL; Stringfellow DA
    Vaccine; 2007 Jan; 25(5):867-76. PubMed ID: 17005300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [How the bovine viral diarrhea virus outwits the immune system].
    Peterhans E; Jungi TW; Schweizer M
    Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):124-9. PubMed ID: 16716045
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis.
    Valle PS; Skjerve E; Martin SW; Larssen RB; Østerås O; Nyberg O
    Prev Vet Med; 2005 Nov; 72(1-2):189-207; discussion 215-9. PubMed ID: 16213612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Bovine virus diarrhea/mucosal disease virus: diagnosis and approach in clinical practice].
    Wentink GH; Zimmer GM; Straver PJ; Moerman A
    Tijdschr Diergeneeskd; 1989 Sep; 114(17):877-85. PubMed ID: 2678589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response to modified live and killed multivalent viral vaccine in regularly vaccinated, fresh dairy cows.
    Dubovi EJ; Gröhn YT; Brunner MA; Hertl JA
    Vet Ther; 2000; 1(1):49-58. PubMed ID: 19757565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Observing BVD infection].
    Tijdschr Diergeneeskd; 2005 Oct; 130(20):636. PubMed ID: 16276735
    [No Abstract]   [Full Text] [Related]  

  • 72. Prevalence of bovine viral diarrhea virus infections in alpacas in the United States.
    Topliff CL; Smith DR; Clowser SL; Steffen DJ; Henningson JN; Brodersen BW; Bedenice D; Callan RJ; Reggiardo C; Kurth KL; Kelling CL
    J Am Vet Med Assoc; 2009 Feb; 234(4):519-29. PubMed ID: 19222364
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.
    Dehan P; Couvreur B; Hamers C; Lewalle P; Thiry E; Kerkhofs P; Pastoret PP
    Vaccine; 2005 Jul; 23(33):4236-46. PubMed ID: 16005739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biosecurity and biocontainment of bovine viral diarrhea virus.
    Smith DR; Grotelueschen DM
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):131-49. PubMed ID: 15062479
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Comparison of performance of dairy herds that were or were not vaccinated with a bovine herpes virus 1 marker vaccine in 1998].
    Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):191-7. PubMed ID: 11285639
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Natural infection of cattle with an atypical 'HoBi'-like pestivirus--implications for BVD control and for the safety of biological products.
    Ståhl K; Kampa J; Alenius S; Persson Wadman A; Baule C; Aiumlamai S; Belák S
    Vet Res; 2007; 38(3):517-23. PubMed ID: 17506974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Knowledge gaps impacting the development of bovine viral diarrhea virus control programs in the United States.
    Ridpath JF; Fulton RW
    J Am Vet Med Assoc; 2009 Nov; 235(10):1171-9. PubMed ID: 19912037
    [No Abstract]   [Full Text] [Related]  

  • 79. [Bovine viral diarrhea control in Russian Federation].
    Guliukin MI; Iurov KP; Glotov AG; Donchenko NA
    Vopr Virusol; 2013; 58(6):13-8. PubMed ID: 24772640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elimination of bovine viral diarrhoea virus in New Zealand: a review of research progress and future directions.
    Han JH; Weir AM; Weston JF; Heuer C; Gates MC
    N Z Vet J; 2018 Nov; 66(6):273-280. PubMed ID: 30091684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.